People · Operator
Named in public records as an officer, director or promoter · active 2010–2026 · Pharmaceuticals, Biotechnology, Business Services, Other Technology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Biotie Therapies Corp. | — | Pharmaceuticals | Series D+ | $149.8M | $214.0M | 2013 |
| PanTheryx, Inc. | — | Biotechnology | Series C | $95.7M | $619.6M | 2010 |
| SHAED, Inc. | — | Business Services | Series A | $6.2M | $13.5M | 2025 |
| DegreeSight Inc | — | Other Technology | Seed | $3.8M | $35.4M | 2021 |
| VitalPoint Technologies, Inc. | — | Biotechnology | Pre-Seed | $300K | $2.4M | 2023 |
DAVID COOK at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside DAVID COOK on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| SCOTT UNGERER | 1 | 5 |
| George Stagnitti | 1 | 3 |
| William Burns | 1 | 3 |
| THOMAS WASHING | 1 | 3 |
| Guido Magni | 1 | 3 |
| Mahendra G. Shah | 1 | 3 |
| George A. Stagnitti | 1 | 2 |
| Scott Chamberlain | 1 | 2 |
| MARK BRAMAN | 1 | 2 |
| Peter Erickson | 1 | 2 |
| David Cogut | 1 | 2 |
| Mark A. Braman | 1 | 2 |
| David Abramson | 1 | 2 |
| Ian Massey | 1 | 2 |
| BIMLA STARZL | 1 | 2 |
| ISMAIL KOLA | 1 | 2 |
| Marie Thompson | 1 | 2 |
| Scott A. Hyman | 1 | 1 |
| THOMAS J. WASHING | 1 | 1 |
| Bimla A. Starzl | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.